logo
Is it perimenopause ... or something else? A new wearable is helping women demystify symptoms like hot flashes and brain fog.

Is it perimenopause ... or something else? A new wearable is helping women demystify symptoms like hot flashes and brain fog.

Yahooa day ago
Many women say they don't feel informed at all about this stage of life.
Why is it suddenly harder to find the right word or remember the name of the restaurant you used to go to? When did sleeping through the night become such a rarity? And what's up with that shoulder pain that came out of nowhere? Welcome to perimenopause — the transition period that kicks off years before you officially reach menopause. While hot flashes and night sweats steal most of the spotlight, there are many subtler and seemingly random symptoms that can crop up (itchy ears, anyone?). It can leave women feeling blindsided and lost, like they're navigating an ever-shifting landscape without a compass or a map.
A 2022 survey of nearly 950 perimenopausal women in the U.K. found that more than 60% said they didn't feel informed at all about this stage of life. Other than hot flashes, 'most of the women were entirely unaware of the wide array of symptoms and so did not connect them to the perimenopause,' according to the study authors.
A more recent survey of nearly 4,500 American women revealed that more than 55% of those ages 30 to 35 had symptoms that could be classified as 'moderate' or 'severe' on the Menopause Rating Scale (MRS), a common questionnaire that measures the intensity of menopause symptoms. That increased to more than 64% in women ages 36 to 40. But the researchers behind the survey found that most women don't talk to a health care professional about their symptoms until they reach their mid-50s. Many just muscle through an uncomfortable array of symptoms.
A lot of it comes down to the fact that almost no one is taught about perimenopause and menopause (and most doctors aren't adequately trained in it), so they may not know what signs to look out for and how to best manage symptoms. Technology is stepping in to fill the gap. The latest: a wearable device that's specifically designed to help women track perimenopause symptoms and figure things out sooner. It's called Peri by identifyHer, and it's a first-of-its-kind tool to help midlife women be better informed about this stage of life and their health. Here's what's behind this innovative technology, plus what menopause experts think.
The problem: Figuring out whether you're in perimenopause is like playing a guessing game — but with your health. And managing symptoms can be difficult if you don't know where to start.
By the numbers: A 2021 survey found that 44% of women were unaware of perimenopause until they started experiencing symptoms, while 46% were not expecting perimenopause when it started. A more recent survey by Ohio State Wexner Medical Center revealed that more than 60% of women believe they will reach menopause in their 40s. However, perimenopausal symptoms can start as early as your 30s, while the average age of menopause is 51, which can catch some women off guard.
The solution: Peri by identifyHer is a wearable device with a corresponding app that's designed for women in perimenopause. It was a 2025 CES Innovation Awards Honoree and is relatively simple to use.
The tool has an adhesive that sticks to your torso and collects data on everything from hot flashes and night sweats to sleep, anxiety and brain fog, sending that information to the app. It also gives personalized feedback on how to manage your specific symptoms.
Chief executive officer and cofounder Heidi Davis tells Yahoo that the device was designed with the goal of supporting women. 'There's a critical lack of support and objective data when it comes to perimenopause — a stage that affects nearly every woman yet is still poorly understood,' she says. 'Beyond helping women in the moment, Peri aims to help close the gender data gap by gathering women-specific health data. Perimenopausal symptoms can be an early signal for future health outcomes, and understanding them better is key to keeping women healthier and more productive for longer.'
Peri continuously monitors perimenopausal symptoms over time to analyze patterns and provide advice on next steps for women. 'These include tailored feedback on lifestyle around diet and exercise, feedback on hormone replacement therapy if applicable and tracking of symptoms across the cycle — helping women identify underlying causes of things like sleep disruption, e.g., is it night sweats? Anxiety?' Davis says. 'It also helps prompt more informed conversations with health care providers by offering a clear picture of what's going on.' Meaning, you can take the app's findings to your doctor to go over what you're experiencing in detail.
Doctors who treat women in perimenopause and menopause say these details can be helpful. 'Digitalized health is one of the best ways to implement health care and to truly understand a patient's progression, recovery and journey through certain medical conditions,' women's health expert Dr. Jessica Shepherd, an ob-gyn in Dallas and author of the book Generation M: Living Well in Perimenopause and Menopause, tells Yahoo. 'The hormonal shifts seen in perimenopause and menopause are able to be tracked with a device such as this, which is valuable, especially since the journey of this transition is very hard to contextualize to a group of women.'
Dr. Lauren Streicher, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, tells Yahoo that a device like this can help women identify symptoms they may not realize are from perimenopause and share them with their health care provider. 'Women are not aware of all of their hot flashes,' she says, pointing out that these can happen overnight when women are sleeping. 'There is value in knowing how many hot flashes you're actually having and whether whatever you're doing to try to make them go away is working,' Streicher says.
That actually matters more than just knowing your health stats. 'There is a correlation between the severity of symptoms in perimenopause, such as hot flashes and night sweats, that can have a direct link to future health implications, such as heart disease, neurodegenerative diseases and overall quality of life,' Shepherd says. 'There is data that shows the increased severity of either hot flashes or night sweats was associated with a higher risk of cardiovascular disease.'
While some experts say the wearable device is useful, Dr. Mary Jane Minkin, a clinical professor of obstetrics and gynecology and reproductive sciences at Yale School of Medicine and founder of Madame Ovary, says you don't need it to help you navigate perimenopause comfortably. 'As a general rule, things that are helpful for perimenopausal symptoms are also very good for medical health in general: getting lots of exercise (both aerobic and strength training) and eating a healthy diet — some varieties of a Mediterranean diet are good for most women,' Minkin tells Yahoo. 'Stopping smoking and avoiding excess alcohol — I discourage women from drinking more than one drink a day — are also good to minimize perimenopausal symptoms.'
Minkin says it's also crucial to find a health care provider who understands perimenopause. (She recommends focusing on providers who are members of the Menopause Society and Menopause Society-certified practitioners.)
Davis says she hopes her tool can help women make sense of what's happening to their bodies at this stage of life. 'Symptoms [of perimenopause] are often dismissed or misattributed, and women are left to manage on their own,' she says. 'There's a massive opportunity to bring clarity, support and personalization to this experience.'
Preorders for Peri open in September 2025, and the first devices will ship in October.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Girl who died in hospital ‘should have been watched at all times', inquest hears
Girl who died in hospital ‘should have been watched at all times', inquest hears

Yahoo

time20 minutes ago

  • Yahoo

Girl who died in hospital ‘should have been watched at all times', inquest hears

A teenager who died after an agency worker with false identity papers left her unsupervised at a children's mental health hospital should have been kept within eyesight at all times, an inquest has heard. Ruth Szymankiewicz was being treated for an eating disorder at Huntercombe Hospital in Berkshire and had been placed under strict one-to-one observation when on February 12 2022 she was able to shut herself in her bedroom alone for 15 minutes, a jury inquest held at Buckinghamshire Coroner's Court heard on Tuesday. The 14-year-old girl self-harmed and died two days later at John Radcliffe Hospital in Oxford. It later emerged the member of staff responsible for watching Ruth at the hospital's psychiatric intensive care unit – a man then known as Ebo Acheampong – had been using false identity documents and was hired under a false name. The teenager was last captured on CCTV walking out of the ward's day room 'completely on her own' before going straight to her bedroom and closing the door behind her, coroner Ian Wade KC told the hearing. Jurors were shown the footage in which 15 minutes pass before a nurse opens the door, then covers her mouth in what appears to be an expression of shock. Ellesha Brannigan, who worked as a clinical team leader on the ward, told the court on Tuesday she ran to Ruth's bedroom after the alarm was raised and found the teenage girl lying unconscious. 'She was just still,' Ms Brannigan said, adding the teenage girl was not breathing and staff initiated chest compressions in an attempt to revive her. About a week prior, Ruth's care plan had been escalated to 'level three observation' after a similar self-harming incident, Ms Brannigan told the court. 'Level three observation is within eyesight at all times,' she told the hearing. Staff members would take turns watching Ruth for 60 minutes at a time, the inquest heard. Ms Brannigan further told the inquest 'level two observation' would have still required a member of staff check on the patient 'every five or 10 minutes'. Asked by the coroner if there were circumstances in which a member of staff responsible for a level three observation could take their eyes off the patient, she replied: 'No. 'If they (the patient) are prescribed level three observation, you must comply with what is prescribed.' The coroner previously said Mr Acheampong will not be giving evidence at the inquest as he fled the UK for Ghana shortly after Ruth's death. The inquest continues.

Raw milk sickens 21 people in Florida including 6 children
Raw milk sickens 21 people in Florida including 6 children

Yahoo

time20 minutes ago

  • Yahoo

Raw milk sickens 21 people in Florida including 6 children

TALLAHASSEE, Fla. (AP) — Six children are among 21 people who have E. coli or campylobacter infections after consuming raw milk from a farm in Florida, public health officials said. Seven people have been hospitalized, and at least two of them are suffering severe complications, the Florida Department of Health said Monday. It did not specify if any of the six infected children under 10 are among those being treated in hospitals, nor how many people were infected by E. coli, campylobacter or both bacteria. 'Sanitation practices in this farm are of particular concern due to the number of cases,' reads the state advisory, which did not identify the farm linked to the cluster of infections in northeast and central Florida. Raw milk appears to be gaining in popularity, despite years of warnings about the health risks of drinking unpasteurized products. The Food and Drug Administration and the Centers for Disease Control and Prevention say raw milk is one of the 'riskiest' foods people can consume. Raw milk is far more likely than pasteurized milk to cause illnesses and hospitalizations because of dangerous bacteria such as campylobacter, listeria, salmonella and E. coli, research shows. The infections can cause gastrointestinal illness, and in some cases may lead to serious complications, including a life-threatening form of kidney failure. Young children, the elderly, immunocompromised people and pregnant women are at greater risk of complications. 'We invented pasteurization for a reason,' said Keith Schneider, a food safety professor at the University of Florida. 'It's maddening that this is happening.' States have widely varying regulations regarding raw milk, with some allowing retail purchases in stores and others allowing sale only at farms. Some states allow 'cowshares,' in which customers buy milk produced by designated animals, and some allow consumption only by farm owners, employees or 'non-paying guests.' In Florida, the sale and distribution of raw milk for human consumption is illegal, but retailers get around the ban by labeling their products as for pet or animal food only. Schneider called it a 'wink, wink, nudge, nudge,' form of regulation. 'Everybody knows that they're selling it for human consumption,' Schneider said, adding that people getting sick — or even seriously ill — from drinking raw milk is 'not a question of if, but when.' ___ Kate Payne is a corps member for The Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Solve the daily Crossword

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Fast Company

time21 minutes ago

  • Fast Company

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Subscribe to the Daily newsletter. Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock. Fast Company reached out for more details on the timeline and will update this post if we hear back.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store